OMEX vs. BLUE

In the year-to-date period, OMEX achieves a 8.57% return, which is significantly higher than BLUE's -40.41% return. Over the past 10 years, OMEX has outperformed BLUE with an annualized return of -19.14%, while BLUE has yielded a comparatively lower -46.19% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Odyssey Marine Exploration, Inc. (OMEX) and bluebird bio, Inc. (BLUE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current OMEX Sharpe Ratio is -0.30, which is higher than the BLUE Sharpe Ratio of -0.45. The chart below compares the historical Sharpe Ratios of OMEX and BLUE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither OMEX nor BLUE has paid dividends to shareholders.

The maximum OMEX drawdown since its inception was -99.70%, roughly equal to the maximum BLUE drawdown of -99.89%. Use the drawdown chart below to compare losses from any high point for OMEX and BLUE.

The current volatility for Odyssey Marine Exploration, Inc. (OMEX) is 32.33%, while bluebird bio, Inc. (BLUE) has a volatility of 42.96%. This indicates that OMEX experiences smaller price fluctuations and is considered to be less risky than BLUE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Odyssey Marine Exploration, Inc. and bluebird bio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.